2020
DOI: 10.3390/brainsci10020083
|View full text |Cite
|
Sign up to set email alerts
|

Combining HF rTMS over the Left DLPFC with Concurrent Cognitive Activity for the Offline Modulation of Working Memory in Healthy Volunteers: A Proof-of-Concept Study

Abstract: It has been proposed that the effectiveness of non-invasive brain stimulation (NIBS) as a cognitive enhancement technique may be enhanced by combining the stimulation with concurrent cognitive activity. However, the benefits of such a combination in comparison to protocols without ongoing cognitive activity have not yet been studied. In the present study, we investigate the effects of fMRI-guided high-frequency repetitive transcranial magnetic stimulation (HF rTMS) over the left dorsolateral prefrontal cortex … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 55 publications
0
10
0
1
Order By: Relevance
“…Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that has been proven to be able to treat a variety of psychiatric and neuropsychiatric disorders, including depression, PTSD, and migraine [18]. In 2008, the US Food and Drug Administration (FDA) cleared the NeuroStar TMS Therapy System as the first device for rTMS treatment of MDD, and it has been adopted into clinical practice [19,20]. The acute antidepressant properties of rTMS delivered to the dorsolateral prefrontal cortex (DLPFC) have been extensively examined [21].…”
Section: Introductionmentioning
confidence: 99%
“…Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that has been proven to be able to treat a variety of psychiatric and neuropsychiatric disorders, including depression, PTSD, and migraine [18]. In 2008, the US Food and Drug Administration (FDA) cleared the NeuroStar TMS Therapy System as the first device for rTMS treatment of MDD, and it has been adopted into clinical practice [19,20]. The acute antidepressant properties of rTMS delivered to the dorsolateral prefrontal cortex (DLPFC) have been extensively examined [21].…”
Section: Introductionmentioning
confidence: 99%
“…The current study covered a broad range of cognitive functions besides the executive functions that were targeted with the training. As previously suggested (81), and demonstrated (82,83), enhancement through NIBS might be a zero-sum proposition, where the enhancement of a cognitive or motor function comes at a cost of other abilities. The possibility that enhancing some cognitive or motor abilities in healthy older individuals could be at the expense of other abilities has clear ethical implications and is an important issue in need of systematic evaluation (84).…”
Section: Neurobiological Reasonsmentioning
confidence: 72%
“…rTMS of left dlPFC has produced moderately consistent effects on RSFC but less consistent cognitive outcomes. Regarding cognitive changes associated with left dlPFC rTMS, eight of twelve studies reviewed here reported significant cognitive improvements associated with high-frequency stimulation [14,33,34,37,38,40,41,[43][44][45]70,71]. Further, one study using low-frequency rTMS reported acute cognitive impairment [42].…”
Section: Review Of Prior Work 21 Organization Of the Reviewmentioning
confidence: 73%